关注
James Paul
James Paul
在 glasgow.ac.uk 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Randomized intergroup trial of cisplatin–paclitaxel versus cisplatin–cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
MJ Piccart, K Bertelsen, K James, J Cassidy, C Mangioni, E Simonsen, ...
Journal of the National Cancer Institute 92 (9), 699-708, 2000
13062000
Duration of adjuvant chemotherapy for stage III colon cancer
A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ...
New England Journal of Medicine 378 (13), 1177-1188, 2018
9542018
Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis
AJ Mitchell, DW Ferguson, J Gill, J Paul, P Symonds
The lancet oncology 14 (8), 721-732, 2013
8712013
Phase III randomized trial of docetaxel–carboplatin versus paclitaxel–carboplatin as first-line chemotherapy for ovarian carcinoma
PA Vasey, GC Jayson, A Gordon, H Gabra, R Coleman, R Atkinson, ...
Journal of the National Cancer Institute 96 (22), 1682-1691, 2004
7942004
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
6512013
Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer
CA Espie, L Fleming, J Cassidy, L Samuel, LM Taylor, CA White, ...
Journal of clinical oncology 26 (28), 4651-4658, 2008
4672008
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ...
Nature genetics 45 (4), 362-370, 2013
4242013
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
4212017
Copy number signatures and mutational processes in ovarian carcinoma
G Macintyre, TE Goranova, D De Silva, D Ennis, AM Piskorz, M Eldridge, ...
Nature genetics 50 (9), 1262-1270, 2018
3932018
The Acquisition of hMLH1 Methylation in Plasma DNA after Chemotherapy Predicts Poor Survival for Ovarian Cancer Patients
G Gifford, J Paul, PA Vasey, SB Kaye, R Brown, ...
Clinical cancer research 10 (13), 4420-4426, 2004
3482004
Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the …
PS Roshanov, B Rochwerg, A Patel, O Salehian, E Duceppe, ...
Anesthesiology 126 (1), 16-27, 2017
3102017
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
3102015
Common variants at 19p13 are associated with susceptibility to ovarian cancer
KL Bolton, J Tyrer, H Song, SJ Ramus, M Notaridou, C Jones, T Sher, ...
Nature genetics 42 (10), 880-884, 2010
2972010
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer
S Marsh, J Paul, CR King, G Gifford, HL McLeod, R Brown
Journal of Clinical Oncology 25 (29), 4528-4535, 2007
2902007
Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial
SC Crawford, PA Vasey, J Paul, A Hay, JA Davis, SB Kaye
Journal of clinical oncology 23 (34), 8802-8811, 2005
2632005
Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes
G Strathdee, K Appleton, M Illand, DWM Millan, J Sargent, J Paul, ...
The American journal of pathology 158 (3), 1121-1127, 2001
2482001
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ...
Journal of medical genetics 53 (12), 800-811, 2016
2422016
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer
SB Kaye, CR Lewis, J Paul, M Soukop, EM Rankin, J Cassidy, JA Davis, ...
The Lancet 340 (8815), 329-333, 1992
2371992
Bridging the special education divide
JE Andrews, DW Carnine, MJ Coutinho, EB Edgar, SR Forness, LS Fuchs, ...
Remedial and Special education 21 (5), 258-267, 2000
2332000
A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma
N O’Rourke, JC Garcia, J Paul, C Lawless, R McMenemin, J Hill
Radiotherapy and oncology 84 (1), 18-22, 2007
2232007
系统目前无法执行此操作,请稍后再试。
文章 1–20